Showing results (2351-2360 of 3,035) with videos related to

Sort By:
Pageof 304
Leukemia Research|June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemiaTamar Tadmor, Ilana Levy, Yair Herishanu, et al.
International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 18, 2014
Impact of CMS coverage decision on access to transcatheter aortic valve replacementBrian P O'Neill, William W O'Neill, Donald Williams, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2022
Comparing Coronavirus Disease 2019 (COVID-19) Pandemic Waves in Hospitalized Patients: A Retrospective, Multicenter, Cohort StudyYaron Niv, Noa Eliakim-Raz, Yaron Bar-Lavi, et al.
The FEBS Journal|April 25, 2023
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myelomaNatalie Berghaus, Sarah Schreiner, Alexandra M Poos, et al.
Biological Psychiatry|May 25, 2016
Genetically Induced Retrograde Amnesia of Associative Memories After Neuroplastin AblationSoumee Bhattacharya, Rodrigo Herrera-Molina, Victor Sabanov, et al.
Blood Advances|May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomizationMolly Went, Alex J Cornish, Philip J Law, et al.
The Journal of Experimental Medicine|April 8, 2009
Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lungMeera G Nair, Yurong Du, Jacqueline G Perrigoue, et al.
Pageof 304